Nvelop Therapeutics

View the org chart displaying its 11 main executives

Most searched biographies at Nvelop Therapeutics

• Jeff Walsh, Chief Executive Officer and Director
• Jess Alston, Director
• Jeff Marrazzo, Independent Board Member

Popular executive movements at Nvelop Therapeutics

• Jeff Walsh has joined the company as Chief Executive Officer  (posted on April 19 2024).
• Lisa Mcgrath has joined the company as Chief People Officer  (posted on April 19 2024).

Create your alert
to follow the executive moves at Nvelop Therapeutics.

Nvelop Therapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Nvelop Therapeutics

Social media about Nvelop Therapeutics

• Nvelop Therapeutics on Wikipedia, Google News & Yahoo Finance
• Nvelop Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Jeff Walsh

Call Nvelop Therapeutics at +1 617...

View the org chart

Register to receive your alert

Report an error